Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia
Qian Wang,Wen‐zhi Cai,Qin‐rong Wang,Ming‐qing Zhu,Ling‐zhi Yan,Yan Yu,Xie‐bing Bao,Hong‐jie Shen,Hong Yao,Jun‐dan Xie,Tong‐tong Zhang,Ling Zhang,Xiao‐yu Xu,Zhe Shan,Hong Liu,Jian‐nong Cen,Dan‐dan Liu,Jin‐lan Pan,Da‐ru Lu,Jia Chen,Yang Xu,Ri Zhang,Ying Wang,Sheng‐li Xue,Miao Miao,Yue Han,Xiao‐wen Tang,Hui‐ying Qiu,Ai‐ning Sun,Jin‐yan Huang,Hai‐ping Dai,De‐pei Wu,Su‐ning Chen
DOI: https://doi.org/10.1002/ajh.26758
IF: 13.265
2022-10-12
American Journal of Hematology
Abstract:Mixed phenotype acute leukemia (MPAL) is a subtype of leukemia in which lymphoid and myeloid markers are co‐expressed. Knowledge regarding the genetic features of MPAL is lacking due to its rarity and heterogeneity. Here, we applied an integrated genomic and transcriptomic approach to explore the molecular characteristics of 176 adult patients with MPAL, including 86 patients with T‐lymphoid/myeloid MPAL (T/My MPAL‐NOS), 42 with Ph+ MPAL, 36 with B‐lymphoid/myeloid MPAL (B/My MPAL‐NOS), 4 with t(v;11q23), and 8 with MPAL, NOS, rare types. Genetically, T/My MPAL‐NOS was similar to B/T MPAL‐NOS but differed from Ph+ MPAL and B/My MPAL‐NOS. T/My MPAL‐NOS exhibited higher CEBPA, DNMT3A, and NOTCH1 mutations. Ph+ MPAL demonstrated higher RUNX1 mutations. B/T MPAL‐NOS showed higher NOTCH1 mutations. By integrating next‐generation sequencing and RNA sequencing data of 89 MPAL patients, we defined eight molecular subgroups (G1–G8) with distinct mutational and gene expression characteristics. G1 was associated with CEBPA mutations, G2 and G3 with NOTCH1 mutations, G4 with BCL11B rearrangement and FLT3 mutations, G5 and G8 with BCR::ABL1 fusion, G6 with KMT2A rearrangement/KMT2A rearrangement‐like features, G7 with ZNF384 rearrangement/ZNF384 rearrangement‐like characteristics. Subsequently, we analyzed single‐cell RNA sequencing data from five patients. Groups G1, G2, G3, and G4 exhibited overexpression of hematopoietic stem cell‐disease‐like and common myeloid progenitor‐disease‐like signatures, G5 and G6 had high expression of granulocyte‐monocyte progenitor‐disease‐like and monocyte‐disease‐like signatures, G7 and G8 had common lymphoid progenitor‐disease‐like signatures. Collectively, our findings indicate that integrative genomic and transcriptomic profiling may facilitate more precise diagnosis and develop better treatment options for MPAL. This article is protected by copyright. All rights reserved.
hematology